About Mirvie
Mirvie is a company based in San Francisco (United States) founded in 2019 by Mads Melbye, Stephen Quake, and Maneesh Jain. It operates as a HealthTech. Mirvie has raised $113.7 million across 5 funding rounds from investors including Comerica, BlackRock and Khosla Ventures. The company has 35 employees as of December 31, 2022. Mirvie offers products and services including Mirvie RNA Platform and Encompass Test. Mirvie operates in a competitive market with competitors including Sera Prognostics, OncoCyte, Epic Sciences, Miroculus and Yourgene Health, among others.
- Headquarter San Francisco, United States
- Employees 35 as on 31 Dec, 2022
- Founders Mads Melbye, Stephen Quake, Maneesh Jain
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Mirvie, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$113.7 M (USD)
in 5 rounds
-
Latest Funding Round
$23.7 M (USD), Series B
Jul 18, 2025
-
Investors
Comerica
& 8 more
-
Employee Count
35
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Mirvie
Mirvie offers a comprehensive portfolio of products and services, including Mirvie RNA Platform and Encompass Test. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
A platform predicting pregnancy complications using blood tests.
A test providing personalized insights into pregnancy health.
Unlock access to complete
Unlock access to complete
Funding Insights of Mirvie
Mirvie has successfully raised a total of $113.7M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $23.7 million completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series B — $23.7M
-
First Round
First Round
(27 Apr 2021)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2025 | Amount | Series B - Mirvie | Valuation |
investors |
|
| Aug, 2023 | Amount | Grant - Mirvie | Valuation |
investors |
|
| May, 2022 | Amount | Debt – Conventional - Mirvie | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Mirvie
Mirvie has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Comerica, BlackRock and Khosla Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on life science and technology sectors
|
Founded Year | Domain | Location | |
|
Multi-stage investment firm invests in healthcare and life sciences companies
|
Founded Year | Domain | Location | |
|
Investment and transformation services for entrepreneurs in technology and finance sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Mirvie
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Mirvie
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Mirvie Comparisons
Competitors of Mirvie
Mirvie operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sera Prognostics, OncoCyte, Epic Sciences, Miroculus and Yourgene Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Sera Prognostics is focused on women's health diagnostics.
|
|
| domain | founded_year | HQ Location |
Non-invasive diagnostic test solutions for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Non-invasive tests for detecting circulating tumor cells are provided.
|
|
| domain | founded_year | HQ Location |
MicroRNA profiling platform is developed to detect genes in samples.
|
|
| domain | founded_year | HQ Location |
Non-invasive prenatal genetic tests and genomic services are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Mirvie
Frequently Asked Questions about Mirvie
When was Mirvie founded?
Mirvie was founded in 2019 and raised its 1st funding round 2 years after it was founded.
Where is Mirvie located?
Mirvie is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Who is the current CEO of Mirvie?
Maneesh Jain is the current CEO of Mirvie. They have also founded this company.
Is Mirvie a funded company?
Mirvie is a funded company, having raised a total of $113.7M across 5 funding rounds to date.
How many employees does Mirvie have?
As of Dec 31, 2022, the latest employee count at Mirvie is 35.
What does Mirvie do?
Mirvie is engaged in developing advanced health technology solutions for pregnancy care. The companys core offering, the Mirvie RNA Platform, uses a simple blood test to analyze tens of thousands of RNA messages, predicting complications like preeclampsia and preterm birth months in advance. Research and clinical validation are conducted to enhance the platforms capabilities. The solutions are aimed at enabling proactive and personalized care for pregnant women. The focus is placed on transforming pregnancy health by providing early insights into unique biological changes. The sector primarily served is healthcare, with an emphasis on maternal and fetal well-being.
Who are the top competitors of Mirvie?
What products or services does Mirvie offer?
Mirvie offers Mirvie RNA Platform and Encompass Test.
Who are Mirvie's investors?
Mirvie has 9 investors. Key investors include Comerica, BlackRock, Khosla Ventures, Gates Foundation, and Decheng Capital.